Peer Review History
| Original SubmissionMarch 16, 2022 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-22-07920 New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona Pellucida PLOS ONE Dear Dr. Okumura Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please respond to the comments as mentioned below, and make all the necessary formatting in the revised version of this manuscript. ============================== Please submit your revised manuscript by Aug 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Birendra Mishra, DVM, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "This work is supported in part by Grants-in-Aid for Scientific Research (C) [Grant Number 25450520] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Grants for Encouragement of Scientific Research from the Research Institute of Meijo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.
In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. Additional Editor comments: The manuscript by Okumura et al; on “New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona Pellucida” is interesting and have used several techniques to prove their hypothesis. However, several important informations are missing. Authors needs to clarify the following comments. Introduction section: It is better to include enough background information, rationale, hypothesis, and objectives of this study for better readability. Line 100-111 explains the results. Authors may consider modifying these statements. Why is this study important, and how will it help the scientific community in the field of poultry science or biology? Materials and Methods: Line 118-119: Although ovary and blood were collected from a local chicken meat processor, the sampling procedure is unclear and needs a clear explanation. The number of hens, sampling, and handling procedures are missing. As this is egg-type chicken, why were samples collected from meat processors? Line 131-133: Approximately 30 ovarian follicles for each growth stage of the yellow follicles were collected from 3 kg of 132 the ovaries of the commercial White-Leghorn hens. This statement is confusing. Figures 1 A, B, and C look blurry, and difficult to understand. Authors may indicate with arrows or other simpler ways to understand for the readers. Same comments for Figure 2. Figure legends (Fig 1-7) are missing. The authors have only provided the Supplementary figure legends. It’s very hard to evaluate the results without figure legends. While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-07920R1New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona PellucidaPLOS ONE Dear Dr. Okumura, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please consider the following major questions raised by reviewer and Academic Editor:
Major concern:
Please submit your revised manuscript by Sep 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Birendra Mishra, DVM, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Authros have adequately responded to the reviewer's comments. However, there are some writing errors in the text of the manuscript, which require English proofreading before the final decision. It is also not clear about the sampling. The authors mentioned that the blood and ovary were collected immediately. Does it mean that samples were collected immediately before scalding in ~63°C of hot water for 80 seconds? Please make these statements clear. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-22-07920R2New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona PellucidaPLOS ONE Dear Dr. Okumura, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: The authors have responded to all the comments, however, there are several writing errors that I had pointed out in the previous version. I have edited/corrected most of the errors and suggested to chem if any errors (see ATTACHED file). Authors need to check further and confirm if there are any writing errors. After confirming the writing error, the manuscript will be acceptable for publication. ============================== Please submit your revised manuscript by Oct 13 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Birendra Mishra, DVM, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
PONE-D-22-07920R3New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona PellucidaPLOS ONE Dear Dr. Okumura, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please respond to the questions raised by the reviewers and also check for any additional writing errors. ============================== Please submit your revised manuscript by Dec 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Birendra Mishra, DVM, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Authors have responded to my comments/suggestions. Thanks [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This research group/lab continues to provide insightful and comprehensive research regarding zona pellucida proteins, especially concerning the avian zona pellucida. The reviewed manuscript fits with the quality that is known with this research group. The research is the most comprehensive study to look at the molecular mechanism concerning the assembly of the zona pellucida (or IPVL). The manuscript follows up on a previous report concerning microheterogenicity of ZPC in the IPVL. However, the current report uses several techniques, some unique such as the creation of a quantifiable ZP3-ZP1 binding sassy. The comprehensive battery of test provides sufficient evidence that supports the authors conclusions and insights that are summarized well in Figure 7. Overall, I do not find any errors in methodology that would prevent this from being published. The manuscript is well written and there are no glaring grammatical errors of note: Only issues worth pointing out: The reason using two different lines WL-G and commercial white leghorns was not clearly communicated. For that matter, the route of euthanasia for the WL-G lines was also not stated. Lines 206-223: Was only one sample per ZP3 spot submitted for LC MADI MS/MS? If not, how many were submitted and was there any error among replicate sequences? Reviewer #2: The manuscript by Okomura and colleagues investigates the role of ZP3 microheterogeneity during maturation of the inner perivitelline layer (IPVL) of the hen egg at the end of rapid follicular growth. IPVL is a structure consisting of protein fibers that cover the oocyte. The mechanisms of its formation in the late stages of follicular maturation is poorly understood until now, and is associated with a key question: how does the formation of this fibrous layer adapt to the high growth rate of the follicles in the last days before ovulation? The size of the follicles indeed increases by about 1 to 4 cm in the last 5-6 days of maturation before ovulation. Okumura's study focused on the last 3 days of follicle maturation (F3, F2 and F1). They first studied the 3D structure of the IPVL using a confocal microscopy approach to observe the orientation and size of protein fibers at these different stages. A 2D-SDS-PAGE study revealed the existence of different isoforms of the ZP3 protein (which is one of the major proteins of the IPVL) whose proportions seem to vary during the last days of follicular maturation. Post-translational modifications were revealed by mass spectrometry for each ZP3 spot identified. Finally, they attempted to demonstrate different affinities towards ZP1 for each ZP3 isoform. This work, although very interesting, lacks clarity and/or precision (especially regarding the methodology and results) and some results (in particular those concerning the ZP1 binding assay) are too preliminary. Some interpretation and conclusions are also questionable, which calls into question the predictive model presented at the end of the manuscript. Consequently, the manuscript needs to be corrected and completed in depth. Substantial modifications are required. Major comments: 1. The lack of reliable information on the orientation of the forming IPVL in the microscopy study is a major issue. The figures and results do not indicate whether the surfaces with 'smooth or homogeneously granular microstructures' (Fig. 1, panels 1, 2, 5, 6) and 'fibrous microstructures' (Fig. 1, panels 3, 4, 7, 8) are oriented towards the granulosa cells or towards the oocyte. Based on the presence of debris, the authors concluded that the "smooth surface of IPVL may be adjacent to the granulosa cell layer in the ovarian follicles" (line 637-638). I assume that the authors think that these debris come from the granulosa cells. But such debris could also be traces of yolk or remnants of the plasma membrane of the oocyte. The orientation needs to be defined more precisely and unambiguously. Is it possible to identify the orientation of the IPVL during the isolation step? This is very important to clarify because the predictive model for the structural maturation of the IPVL discussed in the manuscript strongly relies on the appearance of the surfaces and their orientation in the follicle. Moreover, it should be noted that some results in the literature tend to show the opposite. Indeed, in the fresh egg, the outer surface of the IPVL exposed after separation from the outer layer (i.e. the surface that was theoretically interacting with the granulosa cells) has thick fibers whereas the surface in contact with the yolk content or the oocyte has smaller fibers (In Kido and Doi, 1988, see Figure 4, panels C vs E, https://doi.org/10.3382/ps.0670476). In this case, the surface with the 'fibrous microstructures' could therefore be adjacent to the granulosa cells. 2. The methodology used for the ZP1 binding assay raises many questions impairing the reliability of the results: -The ZP1 binding test does not appear to be specific. The ZP3 crude extracts used are not pure and all bands present, including non-ZP3 bands, are found in the eluted fractions (see silver-stained gel, Fig. S5D). -The protein amounts/concentrations of ZP1 solution and ZP3 crude extracts used are not indicated in the material and method. To compare the binding capacity of different ZP3 fractions, ZP1 beads should normally be incubated with identical amounts of ZP3 protein, but immunoblot results suggest that the starting amounts are different for the different crude extracts used (Figs. 6C and 6G). To overcome this, the authors attempted to normalize their results with the ratio of the starting amount to the eluted amount of ZP3, but this method is not ideal. The presence of more or less abundant contaminating bands or proteins in the ZP3 fractions is problematic. Figures S5B and S5D show that ZP3 band is minor in fraction 10 (crude extract “c”). This fraction even seems to contain contaminating ZP1 protein, which can potentially bind ZP3 protein and prevent it from binding to the ZP1 beads. -The binding assay is based on a quantification of bands obtained by immunoblot in order to identify the isoforms that best bind the ZP1 protein. As the fractions used contain several isoforms, do the authors know if all isoforms are equally recognised by the antibody? Also, the densitometry results sometimes seem to give inconsistent results. For example, in Figure 6C, band “b” in the crude extract appears visually much more intense than bands “a” and “c”, yet the densitometry values do not agree with this observation. In Figure 6G, band e in the crude extract appears much more intense (at least twice more intense) than bands “d” and “f”, but the densitometry values provided are close for all three bands. In the middle panel (elution), band “e” appears to be more intense than the band “f”, but here the densitometry results are the opposite. -There is no information on the number of repeats. Was this test repeated several times? -The authors conclude “these results showed that the ZP3 isoform 7 exhibited much higher binding affinity among ZP3 isoforms 2-8, although there might be possible synergistic effects of these ZP3 isoforms” (line 597-598). The data do not allow to be so affirmative about isoform 7 because fractions “c” and “f”, which according to the authors have the best binding capacity towards ZP1, also contain isoform 6. Why would isoform 7 bind ZP1 better than isoform 6? Furthermore, isoform 7 also appears to be a major component of fraction “e”. It is therefore difficult to conclude with certainty about the isoform that binds ZP1 best. For all these reasons, the results and conclusions of the ZP1-ZP3 binding test appear preliminary and need to be confirmed, either by using (more) pure ZP3 fractions or by using other methodological approaches. Additional comments: 1. The study was carried out on White Leghorn hens from two different origins, namely “commercial White Leghorn” and “long-term closed colony White Leghorn”. Why were two types of animals used in this study? In figure 3, the immunoblots from the “commercial White Leghorn” samples are compared with a coomassie gel from “long-term closed colony White Leghorn” animals. But a silver nitrate gel on the “commercial White Leghorn” is also shown in this figure. Why did the authors choose to compare densitometry results from samples of different origins? In panel B, it would be more rigorous to compare spots from samples from the same animals (e.g. the spots from immunoblots with the spots from the silver stained gel). Furthermore, the statistical analysis in Figure 3B does not mention the number of samples or animals used, nor the number of technical replicates. 2. The IPVL shown in Figures 1B, 1C, S1B, S1C, S1E, S1G (panels 2, 3, 6, 7) appear to have two sublayers. This two-layered structure is quite troubling. Is it an artefact or something real? This is not discussed in the results section. 3. Lines 639-648: This part of discussion could be discussed with regards to the ultrastructural observations of the chicken zona radiata made by Wyburn in 1965: Wyburn GM, Aitken RN, Johnston HS. The ultrastructure of the zona radiata of the ovarian follicle of the domestic fowl. J Anat. 1965 Jul;99(Pt 3):469-84. 4. The text needs to be proofread by a native English reader. Minor remarks: -Figure 1: Scale values in µm are shown in the lower panels, but not in the upper panels. Please homogenise. -Figure 4: the asterisk is not described in the figure legend. -Line 133: the abbreviation MEXT needs to be defined -Line 211: "1% acrylamide" is probably not the right reagent for alkylation. -Line 284: the use of "wt%" is not clear ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 4 |
|
New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona Pellucida PONE-D-22-07920R4 Dear Dr. Okumura, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Birendra Mishra, DVM, PhD Academic Editor PLOS ONE Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-07920R4 New Insights into the Role of Microheterogeneity of ZP3 During Structural Maturation of the Avian Equivalent of Mammalian Zona Pellucida Dear Dr. Okumura: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Birendra Mishra Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .